Search
XEPLION 150 MG, Suspension injectable à libération prolongée en seringue pre-remplie [P]
Details
| --- | Description |
|---|---|
| Pack | Boite d'une seringue pre-remplie et 2 aiguilles |
| Strength (Dosage) | 150 MG |
| Laboratory | MAPHAR |
| Ingredients | Palipéridone |
| Therapeutic class | Neuroleptique atypique |
| ATC code | N05AX13 |
| PPH | $403.90 |
| PPV | $432.40 |
| Refundable | No |
| Refund base | $0.00 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Not specified |
| Uses | Xeplion est indiqué pour le traitement aigu et d'entretien de la schizophrénie. |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications with one or more of the ingredients above
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem